CXCL12 and ischemic stroke: Transplantation of exogenous ESCs/EPCs has shown great potential in the treatment of ischemic stroke [8], [9], and bone marrow cells can be mobilized into the circulation as a stress-induced protective response after injury under the influence of several chemotactic factors, especially stromal cell-derived factor 1 (SDF-1) [10]–[12].